BPC-157: 0.5 mg daily (or 0.25 mg twice daily) TB-500: 2-2.5 mg twice weekly (loading phase) Duration: 4-6 weeks loading, then 2-4 weeks maintenance Maintenance TB-500: 2 mg once weekly Administration: Use separate syringes
Simple, consistent lifestyle adjustments can make a profound difference
Designed for Convenience Without Cutting Corners This program is built around accessibilitybut not at the expense of safety
NNMT is expressed in several tissues, including liver, adipose tissue and skeletal muscle
Interaction with exercise Here is the encouraging part
A randomized, double-blind, controlled phase II trial in advanced renal cell carcinoma (RCC) demonstrated synergistic anticancer effects with the combination of the glutaminase inhibitor telaglenastat (CB-839) and the mTOR inhibitor everolimus (TelaE), which was well tolerated by patients previously treated with TKIs